Syntal Capital Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Syntal Capital Partners's AMGN Position: Q4 2023 in Review
Syntal Capital Partners sold out of Amgen (AMGN) in Q4 2023, closing a stake of 2,746 shares — an estimated $738K sold.
Syntal Capital Partners first reported a position in AMGN in Q2 2014 and held it in 23 quarters. The position peaked at $1.57M in Q3 2020. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.
- Syntal Capital Partners reported no remaining Amgen position as of Q4 2023 after selling out during the quarter.
- Syntal Capital Partners sold 2,746 Amgen shares in Q4 2023, an estimated $738K.
- Syntal Capital Partners first reported a position in Amgen in Q2 2014 and held it in 23 quarters.
- Syntal Capital Partners's Amgen position peaked at $1.57M in Q3 2020.
- 2,715 funds tracked by Wall St. Rank held Amgen as of Q4 2023.
Based on Syntal Capital Partners's 13F filing for Q4 2023, filed 13 Feb 2024.